International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson correlation test (CT) from empirical Bayes estimates (EBEs) for various designs and shrinkages in the context of nonlinear mixed-effect modeling. Clinical trial simulation was performed with a simple pharmacokinetic model with various weight (WT) effects on volume (V). Data sets were analyzed with NONMEM 7.2 using first-order conditional estimation with interaction and stochastic approximation expectation maximization algorithms. The powers of LRT and CT in detecting the link between individual WT and V or clearance were computed to explore hidden or induced correlations, respectively. Although the different designs and variabilities could be rel...
ABSTRACT: Purpose: When information is sparse, individual parameters derived from a non-linear mixed...
The original publication is available at www.springerlink.comInternational audiencePharmacogenetics ...
The original publication is available at www.springerlink.comInternational audiencePharmacogenetics ...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
Shrinkage of empirical Bayes estimates (EBEs) of posterior individual parameters in mixed-effects mo...
Shrinkage of empirical Bayes estimates (EBEs) of posterior individual parameters in mixed-effects mo...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
ABSTRACT: Purpose: When information is sparse, individual parameters derived from a non-linear mixed...
The original publication is available at www.springerlink.comInternational audiencePharmacogenetics ...
The original publication is available at www.springerlink.comInternational audiencePharmacogenetics ...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
International audienceWe compared the powers of the likelihood ratio test (LRT) and the Pearson corr...
Shrinkage of empirical Bayes estimates (EBEs) of posterior individual parameters in mixed-effects mo...
Shrinkage of empirical Bayes estimates (EBEs) of posterior individual parameters in mixed-effects mo...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
International audiencePURPOSE: When information is sparse, individual parameters derived from a non-...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
ABSTRACT: Purpose: When information is sparse, individual parameters derived from a non-linear mixed...
The original publication is available at www.springerlink.comInternational audiencePharmacogenetics ...
The original publication is available at www.springerlink.comInternational audiencePharmacogenetics ...